News Medical

X-Pulse: The future of flexible benchtop NMR spectroscopy

X-Pulse represents a key breakthrough in the versatility of benchtop NMR spectroscopy. Its innovative modular design integrates fully tunable broadband X-nuclei capability, flow chemistry, reaction ...
Business Wire

Tris Pharma Reports Positive Clinical Results of Intranasal Human Abuse Potential Study Indicating Low Abusability of Cebranopadol, an Investigational, First-in-Class Oral Dual ...

– Study met primary endpoint demonstrating cebranopadol is significantly less abusable than oxycodone when taken intranasally (i.e., snorted) with majority of patients indicating no desire to take ...
News Medical

Revolutionizing drug discovery: High-throughput fragment screening with NexMR's X-Pulse benchtop NMR spectrometer

Fragment-based drug design (FBDD) has led to a revolution in contemporary drug discovery, facilitating a bottom-up approach to the identification and evolution of bioactive small molecules into viable ...
Business Wire

Tris Pharma Announces Positive Results from ALLEVIATE-2 Phase 3 Pivotal Trial for Cebranopadol, an Investigational First-in-Class Oral Dual-NMR Agonist, for the Treatment of ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ALLEVIATE-2 Phase 3 pivotal clinical ...
AZoM on MSN

Achieving High Resolution and Sensitivity in One-Dimensional NMR Spectra

High resolution and sensitivity are critical in nuclear magnetic resonance (NMR) spectroscopy. Both can be overdoubled when ...
Morningstar

Tris Pharma Reports Positive Clinical Results of Intranasal Human Abuse Potential Study Indicating Low Abusability of Cebranopadol, an Investigational, First-in-Class Oral Dual ...

– Results highlight novel mechanism of action of cebranopadol, a dual-NMR agonist, where NOP receptor activation minimizes the potential abusability associated with MOP receptor agonists, while still ...